Icon

CABTREO (NDA216632)- (0.15%;3.1%;1.2%)

ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE BAUSCH
0.15%;3.1%;1.2%
No Yes
2040-Dec-28 Expired
None 2026-Oct-20
None No
CABTREO is a combination of clindamycin phosphate (a lincosamide antibacterial), adapalene (a retinoid), and benzoyl peroxide indicated for the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older.
0 0 0
Total Other Developers 2
Drugs with Suitability No
0.15%;3.1%;1.2% ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.